Article
DIS3L, cytoplasmic exosome catalytic subunit, is essential for development but not cell…
medRxiv · 2022 · Brouze, M.; Szpila, M.; Czerwinska, A. M.; Antczak, W.; Mroczek, S.; Kulinski, T. M.; Hojka-Osinska, A. M.; Cysewski, D.; Adamska, D.; Gruchota, J.; Borsuk, E.; Dziembowski, A.
Key facts
| Title | DIS3L, cytoplasmic exosome catalytic subunit, is essential for development but not cell viability in mice. |
|---|---|
| First author | Brouze, M.; Szpila, M.; Czerwinska, A. M.; Antczak, W.; Mroczek, S.; Kulinski, T. M.; Hojka-Osinska, A. M.; Cysewski, D.; Adamska, D.; Gruchota, J.; Borsuk, E.; Dziembowski, A. |
| Journal | medRxiv |
| Published | Dec 14, 2022 |
| DOI | 10.1101/2022.12.14.520403 |
| Devices mentioned | BK110039, DEN000008, K010696, K022086, K103302 |
| Product codes mentioned | JCI, KIP, KIT, NDS, NJT, OOI, PFF, PFT, JIS, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1